New Horizons Clinical Research
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
New Horizons Clinical Research - overview
Established
1988
Location
Cincinnati, OH, US
Primary Industry
Pharmaceuticals
About
Based in Ohio, US, and founded in 1988, New Horizons Clinical Research operates as a multi-therapeutic clinical research organization. The company was founded by Dr. Gregory Gottschlich. In 2017, New Horizons Clinical Research was recapitalized by NaviMed Capital and merged into Velocity Clinical Research, Inc.
The company provides clinical research on hyperlipidemia, diabetes, osteoarthritis, gout, chronic pain, allergy, asthma, chronic obstructive pulmonary disease (COPD), hypertension, and coronary artery disease (CAD).
Current Investors
Velocity Clinical Research Inc.
Primary Industry
Pharmaceuticals
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Company Stage
Add-on
Total Amount Raised
Subscriber access only
New Horizons Clinical Research - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Velocity Clinical Research Inc. | - | ||||||||
| Add-on | Completed | New Horizons Clinical Research | - | ||||||||
| Merger | Completed | New Horizons Clinical Research | - | ||||||||
| Recapitalisation | Completed | New Horizons Clinical Research | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.